Editorial: Functional neuroendocrine tumors
- PMID: 40786182
- PMCID: PMC12332505
- DOI: 10.3389/fendo.2025.1662247
Editorial: Functional neuroendocrine tumors
Keywords: advances in diagnosis and therapy; functional NET; hormonal secretory syndrome; neuroendocrine tumor; rare tumors.
Conflict of interest statement
Author AS was employed by the company GenesisCare Australia Pty Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Comment on
- Editorial on the Research Topic Functional neuroendocrine tumors
References
-
- Daskalakis K. Functioning and nonfunctioning pNENs. Curr Opin Endocr Metab Res. (2021) 18:284–90. doi: 10.1016/j.coemr.2021.04.007 - DOI
-
- Kim JT, Napier DL, Weiss HL, Lee EY, Townsend CM, Evers BM. Neurotensin receptor 3/sortilin contributes to tumorigenesis of neuroendocrine tumors through augmentation of cell adhesion and migration. Neoplasia (United States). (2018) 20:175–81. doi: 10.1016/j.neo.2017.11.012, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources